Thus, EBP50 acts as a tumor suppressor when localized on membranes; however, in glioblastoma cells, EBP50 translocates from the membrane to the cytoplasm, bringing PTEN with it, thereby activating PI3K/Akt signaling at membranes [67]. The gene discussed is NHERF1; the disease is neoplasm.